Mercer Global Advisors
SLDB icon

Mercer Global Advisors’s Solid Biosciences SLDB Stock Holding History

Mercer Global Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Buy
+1,476
New +$11.2K ﹤0.01% 4970

Other funds holding SLDB

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Mercer Global Advisors's SLDB Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Solid Biosciences (SLDB) in Q2 2026: 1,476 shares worth $14.7K. The stake represents ﹤0.01% of the portfolio and ranks #4970 among its holdings.

104 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Mercer Global Advisors held 1,476 shares of Solid Biosciences worth $14.7K as of Q2 2026.
  • Solid Biosciences was a new Mercer Global Advisors position in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4970 holding.
  • 104 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.